COCH (Envoy Medical) ROE % Adjusted to Book Value: 0.00% (As of Mar. 2026)


COCH Envoy Medical Inc COCH
24 GF Score
Price $0.77
GF Value $1.13
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Envoy Medical ROE % Adjusted to Book Value?

Envoy Medical COCH -4.82% 24 ROE % Adjusted to Book Value is 0.00% as of Mar. 2026. GuruFocus rates COCH with a GF Score™ of 24/100 and a GF Value™ of $1.13 (Possible Value Trap). The stock has 6 warning signs investors should review.

Envoy Medical's ROE % for the quarter that ended in Mar. 2026 was 0.00%. Envoy Medical's PB Ratio for the quarter that ended in Mar. 2026 was 4.85. Envoy Medical's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was 0.00%.

Envoy Medical ROE % Adjusted to Book Value Related Terms

Envoy Medical ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Envoy Medical's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Envoy Medical ROE % Adjusted to Book Value Chart

Envoy Medical Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
0.00 0.00 0.00 0.00 0.00

Envoy Medical Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

COCH vs SRTS, QTI, MDAI: ROE % Adjusted to Book Value Comparison

For the Medical Devices subindustry, Envoy Medical's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Envoy Medical ROE % Adjusted to Book Value vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Envoy Medical's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Envoy Medical's ROE % Adjusted to Book Value falls into.


COCH
24GF Score
Envoy Medical Inc COCH
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Envoy Medical ROE % Adjusted to Book Value Calculation

Envoy Medical's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

Envoy Medical's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / 4.85
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 0.00% mean?
Envoy Medical (COCH) has a ROE % Adjusted to Book Value of 0.00% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Envoy Medical and its competitors.
Is Envoy Medical's ROE % Adjusted to Book Value too high?
Envoy Medical's current ROE % Adjusted to Book Value is 0.00%. Overall, Envoy Medical has a GF Score™ of 24/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Envoy Medical's ROE % Adjusted to Book Value compare to SRTS and QTI?
Envoy Medical's ROE % Adjusted to Book Value of 0.00% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Devices & Instruments company?
A good ROE % Adjusted to Book Value depends on the Medical Devices & Instruments industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Envoy Medical and its competitors. Envoy Medical's current ROE % Adjusted to Book Value is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Envoy Medical stock overvalued right now?
Based on GuruFocus' analysis, Envoy Medical (COCH) is currently considered Possible Value Trap. The stock's GF Value™ is $1.13, compared to a current price of $0.77 — trading 32% below its estimated fair value. The current ROE % Adjusted to Book Value is 0.00%. Envoy Medical's overall GF Score™ is 24/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Envoy Medical (COCH), the current ROE % Adjusted to Book Value is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Envoy Medical (COCH) Overvalued in 2026?

Based on GuruFocus' analysis, Envoy Medical stock appears to be undervalued. The current stock price of $0.77 is trading 32% below its estimated GF Value™ of $1.13. GuruFocus considers Envoy Medical to be Possible Value Trap.

Key valuation signals for COCH:

  • ROE % Adjusted to Book Value: 0.00%
  • GF Value™: $1.13 vs. price of $0.77 (32% below fair value)
  • GF Score™: 24/100 with 6 warning signs

No single metric tells the full story. See the COCH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Envoy Medical Business Description

Address 4875 White Bear Parkway, White Bear Lake, MN, USA, 55110
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.
24GF Score

Get the complete analysis for COCH

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.77
Price
$1.13
GF Value